These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6702732)

  • 1. Pathologic hyperfibrinolysis associated with amyloidosis: clinical response to epsilon amino caproic acid.
    Chang JC; Kane KK
    Am J Clin Pathol; 1984 Mar; 81(3):382-7. PubMed ID: 6702732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolysis and acquired alpha-2 plasmin inhibitor deficiency in amyloidosis.
    Meyer K; Williams EC
    Am J Med; 1985 Sep; 79(3):394-6. PubMed ID: 4036990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated urokinase-type plasminogen activator level and bleeding in amyloidosis: case report and literature review.
    Sane DC; Pizzo SV; Greenberg CS
    Am J Hematol; 1989 May; 31(1):53-7. PubMed ID: 2495717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Massive bleeding with fibrinolysis: management with heparin and epsilon aminocaproic acid.
    Bergin JJ; Crosby WH; Jahnke EJ
    Mil Med; 1966 Apr; 131(4):340-4. PubMed ID: 4955920
    [No Abstract]   [Full Text] [Related]  

  • 5. [EXISTENCE OF CHANGES IN HEMOSTASIS WITH DECREASED FIBRINOLYSIS. BASIS FOR THE HEMOSTATIC TREATMENT WITH EPSILON AMINOCAPROIC ACID IN NON FIBRINOLYTIC HEMORRHAGIC DIATHESIS].
    CASTILLO R; SERRANO J; CARALPS A; VINAS M
    Med Clin (Barc); 1963 Oct; 41():302-6. PubMed ID: 14125259
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary amyloidosis and myelomatosis associated with excessive fibrinolytic acitivty.
    Millard LG; Rowell NR
    Br J Dermatol; 1976 May; 94(5):569-71. PubMed ID: 1268067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation.
    Kang Y; Lewis JH; Navalgund A; Russell MW; Bontempo FA; Niren LS; Starzl TE
    Anesthesiology; 1987 Jun; 66(6):766-73. PubMed ID: 3296855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of bleeding after renal biopsy with epsilon-amino-caproic acid.
    Savdie E; Mahony JF; Storey BG
    Br J Urol; 1978 Feb; 50(1):8-11. PubMed ID: 630206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [FIBRINOLYSIS; APPLICATION IN THE CLINIC (EPSILON-AMINOCAPROIC ACID)].
    MOERS AM; BOSMAN GA
    Folia Med Neerl; 1964 Dec; 7():175-8. PubMed ID: 14265805
    [No Abstract]   [Full Text] [Related]  

  • 10. Amyloidosis with and unusual bleeding diathesis; observations on the use of epsilon amino caproic acid.
    REDLEAF PD; DAVIS RB; KUCINSKI C; HOILUND L; GANS H
    Ann Intern Med; 1963 Feb; 58():347-54. PubMed ID: 13973518
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of frusemide and epsilon-amino-caproic-acid in transurethral prostatectomy. a review after 7 years.
    Smart CJ
    Br J Urol; 1982 Aug; 54(4):437. PubMed ID: 7116117
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment of skeletal hemangioma and Kasabach-Merritt syndrome with aminocaproic acid. Is fibrinolysis "defensive"?
    Neidhart JA; Roach RW
    Am J Med; 1982 Sep; 73(3):434-8. PubMed ID: 7124770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased fibrinolysis and amyloidosis.
    Liebman H; Chinowsky M; Valdin J; Kenoyer G; Feinstein D
    Arch Intern Med; 1983 Apr; 143(4):678-82. PubMed ID: 6340622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FIBRINOLYTIC BLEEDING AND ITS MANAGEMENT.
    SHERRY S; FLETCHER AP; ALKJAERSIG N
    Ann N Y Acad Sci; 1964 Jul; 115():481-92. PubMed ID: 14192857
    [No Abstract]   [Full Text] [Related]  

  • 15. [EPSILON-AMINO-CAPROIC ACID IN THE TREATMENT OF HEMORRHAGIC DISEASE OF THE NEWBORN].
    MARZETTI L
    Quad Clin Ostet Ginecol; 1964 Nov; 19():721-5. PubMed ID: 14279386
    [No Abstract]   [Full Text] [Related]  

  • 16. epsilon-Amino-caproic acid in the management of acute promyelocytic leukaemia.
    Keane TJ; Gorman AM; O'Connell LG; Fennelly JJ
    Acta Haematol; 1976; 56(4):202-4. PubMed ID: 826076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CIRCULATING FIBRINOLYTIC ACTIVATOR AND HEMORRHAGIC DIATHESIS.
    ENDE N; AUDITORE JV
    Ann Surg; 1963 Jul; 158(1):117-25. PubMed ID: 14042622
    [No Abstract]   [Full Text] [Related]  

  • 18. [PRELIMINARY OBSERVATIONS ON THE THERAPEUTIC EFFICACY OF EPSILON-AMINO-CAPROIC ACID IN HEMORRHAGIC SYNDROMES DUE TO BLOOD PLATELET DEFECTS].
    MANDELLI F; DERIU L; OMODEI-ZORINI C
    Policlinico Prat; 1964 Sep; 71():1454-7. PubMed ID: 14204185
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombogenic properties of epsilon amino caproic acid.
    Gans H
    Ann Surg; 1966 Feb; 163(2):175-8. PubMed ID: 5906607
    [No Abstract]   [Full Text] [Related]  

  • 20. EXPERIMENTAL VENOUS THROMBOSIS IN RATS. INCREASED FORMATION DURING INHIBITION OF THE FIBRINOLYTIC SYSTEM WITH EPSILON AMINO CAPROIC ACID.
    NORDOEY A
    Thromb Diath Haemorrh; 1963 Jul; 143():427-35. PubMed ID: 14081264
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.